Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of subzero saline chilling on broiler chilling efficiency, meat quality, and microbial safety.

Poultry science·2020
Same author

Insomnia and daytime sleepiness predict 20-year mortality in older male adults: data from a population-based study.

Sleep medicine·2020
Same author

Improvement of chilling efficiency and meat tenderness of broiler carcasses using subzero saline solutions.

Poultry science·2019
Same author

miR-30e* is an independent subtype-specific prognostic marker in breast cancer.

British journal of cancer·2015
Same author

Hematological and serum biochemical profile of farm emus (Dromaius novaehollandiae) at the onset of their breeding season.

Poultry science·2013
Same author

Ivermectin residues in squab.

Poultry science·2012

Related Experiment Video

Updated: Jun 16, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation.

P J Mishra1, L Ha, J Rieker

  • 1Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, MD 20892-4264, USA.

Oncogene
|February 2, 2010
PubMed
Summary

Investigating NRas downstream effectors in melanoma, this study found that while BRAF and PI3K influence senescence and invasiveness, Ral guanine exchange factor (RalGEF) activation significantly impacts malignant growth, suggesting it as a potential therapeutic target.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Experiment Videos

Last Updated: Jun 16, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cutaneous malignant melanoma is a deadly cancer known for metastasis and therapy resistance.
  • Melanomas frequently harbor oncogenic NRAS or BRAF mutations, which rarely coexist, suggesting overlapping functions.
  • NRAS downstream effectors, including Raf, PI3K, and RalGEF, are critical in melanoma pathogenesis.

Purpose of the Study:

  • To compare the oncogenic roles of three major NRas downstream effectors: Raf, PI3K, and RalGEF.
  • To elucidate the specific contributions of these pathways to melanoma development and progression.
  • To identify potential novel therapeutic targets within the NRas signaling network.

Main Methods:

  • Utilized genetically engineered Arf-deficient immortalized mouse melanocytes as a model system.
  • Compared and contrasted the functional consequences of activating Raf, PI3K, and RalGEF pathways.
  • Assessed key malignant phenotypes including senescence, invasiveness, and anchorage-independent growth.

Main Results:

  • No single NRas effector pathway fully replicated all oncogenic NRas consequences.
  • BRAF activation was linked to melanocyte senescence.
  • PI3K activation was associated with increased melanocyte invasiveness.
  • Constitutive RalGEF activation significantly impacted multiple malignant phenotypes, notably anchorage-independent growth.

Conclusions:

  • While BRAF and PI3K play roles in specific melanoma phenotypes, RalGEF activation demonstrates a broader impact on malignant transformation.
  • The RalGEF pathway, often overlooked, warrants further investigation as a potential therapeutic target in melanoma.
  • Understanding the distinct and overlapping roles of NRas downstream effectors is crucial for developing effective melanoma therapies.